Compare AUB & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUB | CAI |
|---|---|---|
| Founded | 1902 | 2008 |
| Country | United States | United States |
| Employees | 3064 | 1846 |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.7B |
| IPO Year | N/A | N/A |
| Metric | AUB | CAI |
|---|---|---|
| Price | $40.27 | $18.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 11 |
| Target Price | ★ $41.88 | $30.91 |
| AVG Volume (30 Days) | 882.1K | ★ 2.6M |
| Earning Date | 04-21-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.98% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $29.16 | $25.24 |
| Revenue Next Year | $4.59 | $22.32 |
| P/E Ratio | $19.68 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.86 | $14.19 |
| 52 Week High | $42.18 | $42.50 |
| Indicator | AUB | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 66.51 | 56.57 |
| Support Level | $36.35 | $17.21 |
| Resistance Level | $40.71 | $19.79 |
| Average True Range (ATR) | 0.85 | 1.07 |
| MACD | 0.28 | 0.33 |
| Stochastic Oscillator | 97.45 | 91.19 |
Atlantic Union Bankshares Corp is a financial and bank holding company based in the U.S. Through its community bank subsidiary and non-bank financial services affiliates, the company provides financial services, including banking, trust, and wealth management. It offers consumers and businesses a wide range of banking and related financial services, including checking, savings, certificates of deposit, and other depository services, as well as loans for commercial, industrial, residential mortgage, and consumer purposes. The company operates through two reportable operating segments: Wholesale Banking and Consumer Banking, with corporate support functions such as corporate treasury and others included in Corporate Other. It derives maximum revenue from the Wholesale Banking segment.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.